These naturally occurring compounds have been shown to modulate the activity of LXRs and could offer potential therapeutic efficacy, while suppressing SREBP1c target genes to minimize side effects [13], such as hypertriglyceridemia [41]. This evidence concerns the gene SREBF1 and hypertriglyceridemia.